Author: Ken Dropiewski

Acarix accelerates US market entry with Proximo Medical as commercialization partner

Press release (MAR) Malmö, Sweden, November 9, 2021 Acarix accelerates US market entry with Proximo Medical as commercialization partner Acarix today announced the signing of a Commercial Access agreement with Proximo Medical, LLC, to rapidly initiate the commercialization of the CADScor system in the US market. With the agreement, Acarix immediately gains […]

OmniLife and ACTION Network Solidify Collaboration to Drive Innovation

LEXINGTON, Ky.–(BUSINESS WIRE)–OmniLife, a health technology communication and collaboration platform, has finalized its formal collaboration with the Advanced Cardiac Therapies Improving Outcomes Network, or ACTION. The organizations will work together to drive innovation around patient care and clinical decision making, specifically with the goal of improving outcomes for children with […]

Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program

IRVINE, Calif., Nov. 6, 2021 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW) announced that results from a clinical trial of the company’s EVOQUE transcatheter tricuspid valve replacement system demonstrated that favorable patient outcomes were sustained at six months. Results from the TRISCEND study, treating patients with tricuspid regurgitation, were presented during the late-breaking clinical […]

Medtronic self-expanding TAVR platform shows excellent longer-term performance at five years in SURTAVI Trial

TCT 2021: Intermediate risk TAVR patients demonstrate strong hemodynamics and stable valve performance at five years DUBLIN and ORLANDO, Fla., Nov. 5, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today unveiled five-year clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial, which was presented as a Late […]

BioSig Installs its Signal Processing Technology for Arrhythmia Care at a Leading Hospital in Boston

Latest installation follows a steady rise in patient cases conducted with the PURE EP™ System Westport, CT, Nov. 08, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]

Imara to Report Data Demonstrating the Potential of Tovinontrine (IMR-687) for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

Preclinical data from three different mouse models of HFpEF to be presented at American Heart Association (AHA) Scientific Sessions HFpEF development to be led by cardiologist Toni Bransford, M.D., FACC, FASE Imara’s new Vice President of Clinical Development BOSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage […]

Philips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of Cardiologs

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and […]